| Detailed Price Information Link | ||||||||||||||||||||
| BACTERIA |  How to read the following data (Example) | |||||||||||||||||||
| Name: | Klebsiella pneumoniae (Schroeter 1886) Trevisan 1887 | |||||||||||||||||||
| DSM No.: | 681 dsm-681 dsm681 dsm 681 Klebsiella pneumoniae | |||||||||||||||||||
| Strain designation: | PCI 602 | |||||||||||||||||||
| Other collection no. or WDCM no.: | ATCC 10031,NCIB 9111,NCTC 7427 | |||||||||||||||||||
| Isolated from: | unknown source | |||||||||||||||||||
| Country: | country of origin unknown | |||||||||||||||||||
| Date of sampling: | before 1976-01-21 | |||||||||||||||||||
| Nagoya Protocol Restrictions: | There are NO known Nagoya Protocol restrictions for this strain. | |||||||||||||||||||
| History: | <- NCTC; NCTC 7427 (Klebsiella aerogenes) <- ATCC; ATCC 10031 <- U.S. Food and Drug Administration (FDA), Washington, D.C., USA; PCI 602 | |||||||||||||||||||
| Cultivation conditions: | Medium 92 , 37°C or Medium 693 , 37°C Incubation time: 1-2 days Complete DSMZ Media List | |||||||||||||||||||
| Summary and additional information: | <- NCTC; NCTC 7427 (Klebsiella aerogenes) <- ATCC; ATCC 10031 <- U.S. Food and Drug Administration (FDA), Washington, D.C., USA; PCI 602. Unknown source. country of origin unknown. Produces D-ribulokinase (6183). (Medium 92, incubation time: 1-2 days, pH 7, 37°C, aerobic or Medium 693, incubation time: 1-2 days, pH 7, 37°C, aerobic) | |||||||||||||||||||
| Literature: | 738, 1550, 1561, 1562, 1564, 6183 | |||||||||||||||||||
| Risk group: | 2 (classification according to German TRBA) | |||||||||||||||||||
| Restrictions: | Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz), Category A1 | |||||||||||||||||||
| Supplied as: |
Freight and handling charges will be added. See price list. Note: Freight charges for Risk Group 2 microorganisms will apply. | |||||||||||||||||||
| Other cultures: | All DSMZ cultures of the species | |||||||||||||||||||
| Print data sheet | ||||||||||||||||||||
